Desire + Performance Tablet
Tadalafil combined with PT-141 and oxytocin, in one dissolving tablet.
- Contains tadalafil, plus PT-141 and oxytocin
- Supports both performance and desire
- Compounded medication. Not FDA-approved.
Card authorized at checkout. Charged only if a provider approves.
Product images are for illustration only. Actual packaging may vary.
The Desire + Performance Tablet is a compounded prescription drug that contains tadalafil, oxytocin and PT-141 (bremelanotide) and is used to treat erectile dysfunction (ED) and support sexual desire. Compounded drugs are permitted to be prescribed under federal law, but are not FDA-approved and do not undergo FDA safety, effectiveness, or manufacturing review. PT-141 can briefly raise blood pressure. Do not take it more than once in any 24-hour period or within 24 hours of taking any other ED medication. See Important Safety Information.
The short version.
What is the Desire + Performance Tablet?
A dissolving tablet that combines tadalafil with PT-141 (bremelanotide) and oxytocin.
What makes the Desire + Performance Tablet different?
Tadalafil supports erectile function, while PT-141 (bremelanotide) acts on pathways in the brain involved in sexual desire. Bremelanotide is not FDA-approved for use in men.
How much does the Desire + Performance Tablet cost?
$133 per month. No membership fee.
Three simple
steps.
Get prescribed
Complete a secure online visit, and a licensed provider reviews your health history.
Let it dissolve
Place the tablet in your mouth as directed and let it dissolve fully.
Be ready
Sexual arousal is still needed for it to work.
From your phone
to your door.
Your card is authorized at checkout, but you are only charged if a provider approves your treatment.
Complete a short online visit with a few health questions
Hear from your provider
Most orders arrive within a few business days of approval, with tracking sent when your order ships
Begin treatment, with your care team a message away
Find the
right fit.
Your provider confirms which option is appropriate for you.
| Treatment | What it is | Price |
|---|---|---|
| 3-in-1 Performance Film Featured | Sildenafil + tadalafil + oxytocin · dissolving film | $133/moBilled monthly · ships monthly |
| Desire + Performance Tablet | Tadalafil + oxytocin + PT-141 · dissolving tablet | $133/moBilled monthly · ships monthly |
| Arousal Spray | Oxytocin · nasal spray | Starting at $126/moBilled $378 every 3 months · 3-month plan · ships every 3 months (or $140 monthly) |
| Desire Strip | PT-141 (bremelanotide) 2 mg · dissolving strip | Starting at $129.60/moBilled $388.80 every 3 months · 3-month plan · ships every 3 months (or $144 monthly) |
Questions, answered.
How do I take it?
Place the tablet under your tongue and allow it to dissolve completely, before sexual activity as directed by your provider. Do not chew it or swallow it whole. Do not take more than one tablet in 24 hours.
What does PT-141 do?
It acts on pathways in the brain involved in sexual desire.
Can I take more than one?
No. Use it no more than once in 24 hours.
Can I take it with other ED medications?
No. Don't use it within 24 hours of any other medicine containing sildenafil or tadalafil.
Do I need a prescription?
Yes. Complete a short online visit to see if this treatment is right for you. A licensed provider reviews your answers and decides whether it's appropriate to prescribe.
Who makes the treatment decision?
Licensed providers make all consultation and prescribing decisions. Purchasing does not guarantee a prescription. Prescriptions are issued only after a licensed provider reviews your information and determines that treatment is appropriate.
What the research says.
The studies discussed here may involve different formulations, doses, delivery methods, or patient populations from the treatment offered. They do not establish the safety or effectiveness of this specific compounded product. Compounded medications are not FDA-approved; FDA does not review their safety, effectiveness, or quality before marketing.
Oral drug treatments of erectile dysfunction: A AFU/SFMS systematic review,
What was studied. A systematic review of 87 studies of oral erectile dysfunction treatments.
What researchers found. Sildenafil and tadalafil are established treatments for erectile dysfunction. Your clinician selects the medication and dosing schedule based on your health history, preferences, and treatment response.
How it relates to this treatment. Studies of standard oral tablets do not establish that compounded combinations (troches, films or dissolving tablets) work, work faster, or outperform single-ingredient therapy.
“Oral drug treatments of erectile dysfunction: A AFU/SFMS systematic review,” 2025. PMID: 40915356.
Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials.
What was studied. The RECONNECT studies randomized 1,267 premenopausal women with hypoactive sexual desire disorder to subcutaneous bremelanotide 1.75 mg or placebo.
What researchers found. Bremelanotide improved sexual desire and reduced related distress versus placebo. Nausea, flushing and headache occurred more often with treatment.
How it relates to this treatment. Bremelanotide has been studied as a subcutaneous injection for premenopausal women. These results do not establish the effectiveness of compounded dissolving strips, or effectiveness in men.
Kingsberg et al., “Bremelanotide for the Treatment of Hypoactive Sexual Desire Disorder: Two Randomized Phase 3 Trials.” Obstetrics & Gynecology, 2019. PMID: 31599840.
Effect of long-term intranasal oxytocin on sexual dysfunction in premenopausal and postmenopausal women: a randomized trial,
What was studied. A randomized trial of intranasal oxytocin in women, and a study of 29 couples.
What researchers found. Intranasal oxytocin has been investigated for sexual experiences and partner interactions, but findings are mixed. In the 2015 trial, both oxytocin and placebo groups improved, without a statistically significant difference.
How it relates to this treatment. Research has not established a reliable improvement in sexual desire or function, and these studies did not test dissolving strips or combination products.
“Effect of long-term intranasal oxytocin on sexual dysfunction in premenopausal and postmenopausal women: a randomized trial,” 2015. PMID: 26151620. Also: “Differential effects of intranasal oxytocin on sexual experiences and partner interactions in couples,” 2014. PMID: 24503174.
What to know before starting Desire + Performance Tablet.
Other ways
we can help.
The Desire + Performance Tablet is a compounded prescription drug that contains tadalafil, oxytocin and PT-141 (bremelanotide) and is used to treat erectile dysfunction (ED) and support sexual desire. Compounded drugs are permitted to be prescribed under federal law, but are not FDA-approved and do not undergo FDA safety, effectiveness, or manufacturing review. PT-141 can briefly raise blood pressure. Do not take it more than once in any 24-hour period or within 24 hours of taking any other ED medication.
We serve patients in 46 states. We do not currently provide services in Alaska, Mississippi, New Jersey or Texas. Availability can vary by product, depending on whether the dispensing pharmacy is licensed to ship to your state.
Licensed providers make all consultation and prescribing decisions. Purchasing does not guarantee a prescription. Prescriptions are issued only after a licensed provider reviews your information and determines that treatment is appropriate. Your card is authorized at checkout, but you are only charged if a provider approves your treatment.